ValiRx plc (LON:VAL – Get Free Report)’s stock price rose 29.2% during trading on Tuesday. The stock traded as high as GBX 0.19 and last traded at GBX 0.17. 105,847,453 shares traded hands during trading, an increase of 921% from the average session volume of 10,371,050 shares. The stock had previously closed at GBX 0.13.
ValiRx Price Performance
The business’s 50 day simple moving average is GBX 0.14 and its 200-day simple moving average is GBX 0.19. The stock has a market capitalization of £2.22 million, a P/E ratio of -0.41 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. Research analysts anticipate that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
